240 related articles for article (PubMed ID: 28802175)
1. Conjugate of biotin with silicon(IV) phthalocyanine for tumor-targeting photodynamic therapy.
Li K; Qiu L; Liu Q; Lv G; Zhao X; Wang S; Lin J
J Photochem Photobiol B; 2017 Sep; 174():243-250. PubMed ID: 28802175
[TBL] [Abstract][Full Text] [Related]
2. A biotin receptor-targeted silicon(IV) phthalocyanine for in vivo tumor imaging and photodynamic therapy.
Li K; Dong W; Liu Q; Lv G; Xie M; Sun X; Qiu L; Lin J
J Photochem Photobiol B; 2019 Jan; 190():1-7. PubMed ID: 30453160
[TBL] [Abstract][Full Text] [Related]
3. Chlorin e6-Biotin Conjugates for Tumor-Targeting Photodynamic Therapy.
Liu W; Ma X; Jin Y; Zhang J; Li Y; Tang Y; Song Y; Wang S
Molecules; 2021 Dec; 26(23):. PubMed ID: 34885922
[TBL] [Abstract][Full Text] [Related]
4. Targeted Photodynamic Therapy (PDT) of Lung Cancer with Biotinylated Silicon (IV) Phthalocyanine.
Dong W; Li K; Wang S; Qiu L; Liu Q; Xie M; Lin J
Curr Pharm Biotechnol; 2021; 22(3):414-422. PubMed ID: 32386488
[TBL] [Abstract][Full Text] [Related]
5. The first silicon(IV) phthalocyanine-nucleoside conjugates with high photodynamic activity.
Shen XM; Zheng BY; Huang XR; Wang L; Huang JD
Dalton Trans; 2013 Aug; 42(29):10398-403. PubMed ID: 23774802
[TBL] [Abstract][Full Text] [Related]
6. A piperazine-substituted phthalocyanine with rapid cellular uptake and dual organelle-targeting for in vitro photodynamic therapy.
Wu H; Liu G; Chen K; Zhang T; Ye Q; Chen J; Peng Y
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103818. PubMed ID: 37788794
[TBL] [Abstract][Full Text] [Related]
7. Size-Tunable Targeting-Triggered Nanophotosensitizers Based on Self-Assembly of a Phthalocyanine-Biotin Conjugate for Photodynamic Therapy.
Li D; Wang XZ; Yang LF; Li SC; Hu QY; Li X; Zheng BY; Ke MR; Huang JD
ACS Appl Mater Interfaces; 2019 Oct; 11(40):36435-36443. PubMed ID: 31525892
[TBL] [Abstract][Full Text] [Related]
8. Highly selective mitochondria-targeting amphiphilic silicon(IV) phthalocyanines with axially ligated rhodamine B for photodynamic therapy.
Zhao Z; Chan PS; Li H; Wong KL; Wong RN; Mak NK; Zhang J; Tam HL; Wong WY; Kwong DW; Wong WK
Inorg Chem; 2012 Jan; 51(2):812-21. PubMed ID: 22191427
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic Acid Grafted Nanoparticles of a Platinum(II)-Silicon(IV) Phthalocyanine Conjugate for Tumor and Mitochondria-Targeted Photodynamic Therapy in Red Light.
Mitra K; Samso M; Lyons CE; Hartman MCT
J Mater Chem B; 2018 Dec; 6(45):7373-7377. PubMed ID: 31372221
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy effect of morpholinium containing silicon (IV) phthalocyanine on HCT-116 cells.
Yalçın CÖ; Barut B; Barut EN; Demirbaş Ü; Dinçer T; Engin S; Özel A; Sena Sezen F
Photodiagnosis Photodyn Ther; 2020 Dec; 32():101975. PubMed ID: 32835884
[TBL] [Abstract][Full Text] [Related]
11. Functional titanium dioxide nanoparticle conjugated with phthalocyanine and folic acid as a promising photosensitizer for targeted photodynamic therapy in vitro and in vivo.
Liang X; Xie Y; Wu J; Wang J; Petković M; Stepić M; Zhao J; Ma J; Mi L
J Photochem Photobiol B; 2021 Feb; 215():112122. PubMed ID: 33433386
[TBL] [Abstract][Full Text] [Related]
12. Killing efficacy of a new silicon phthalocyanine in human melanoma cells treated with photodynamic therapy by early activation of mitochondrion-mediated apoptosis.
Barge J; Decréau R; Julliard M; Hubaud JC; Sabatier AS; Grob JJ; Verrando P
Exp Dermatol; 2004 Jan; 13(1):33-44. PubMed ID: 15009114
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic effects of new silicon phthalocyanines: in vitro studies utilizing rat hepatic microsomes and human erythrocyte ghosts as model membrane sources.
Zaidi SI; Agarwal R; Eichler G; Rihter BD; Kenney ME; Mukhtar H
Photochem Photobiol; 1993 Aug; 58(2):204-10. PubMed ID: 8415911
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and photodynamic activities of integrin-targeting silicon(IV) phthalocyanine-cRGD conjugates.
Zheng BY; Yang XQ; Zhao Y; Zheng QF; Ke MR; Lin T; Chen RX; Ho KKK; Kumar N; Huang JD
Eur J Med Chem; 2018 Jul; 155():24-33. PubMed ID: 29852329
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of novel Schiff base-silicon (IV) phthalocyanine complex for photodynamic therapy of breast cancer cell lines.
Sarı C; Değirmencioğlu İ; Eyüpoğlu FC
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103504. PubMed ID: 36907257
[TBL] [Abstract][Full Text] [Related]
16. Arginine mediated photodynamic therapy with silicon(IV) phthalocyanine photosensitizers.
Balcik-Ercin P; Ekineker G; Salik N; Aydoğdu B; Yagci T; Göksel M
Photodiagnosis Photodyn Ther; 2023 Sep; 43():103667. PubMed ID: 37355078
[TBL] [Abstract][Full Text] [Related]
17. Preparation and in vitro photodynamic activity of novel silicon(IV) phthalocyanines conjugated to serum albumins.
Huang JD; Lo PC; Chen YM; Lai JC; Fong WP; Ng DK
J Inorg Biochem; 2006 May; 100(5-6):946-51. PubMed ID: 16412511
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric silicon phthalocyanine based nanoparticle with spatiotemporally targeting of mitochondria for synergistic apoptosis-ferroptosis antitumor treatment.
Huang Y; Liu G; Zheng F; Chen J; Lin Y; Wang J; Huang Y; Peng Y
Colloids Surf B Biointerfaces; 2024 Jun; 238():113890. PubMed ID: 38608462
[TBL] [Abstract][Full Text] [Related]
19. A tumor-targeted activatable phthalocyanine-tetrapeptide-doxorubicin conjugate for synergistic chemo-photodynamic therapy.
Ke MR; Chen SF; Peng XH; Zheng QF; Zheng BY; Yeh CK; Huang JD
Eur J Med Chem; 2017 Feb; 127():200-209. PubMed ID: 28063352
[TBL] [Abstract][Full Text] [Related]
20. A non-aggregated silicon(IV) phthalocyanine-lactose conjugate for photodynamic therapy.
Li D; Hu QY; Wang XZ; Li X; Hu JQ; Zheng BY; Ke MR; Huang JD
Bioorg Med Chem Lett; 2020 Jun; 30(12):127164. PubMed ID: 32291134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
